SANDEEP GILL: Open Payments
NPI 1972910016 · RIALTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$531 in 17 payments from 7 companies in 2025. Trend: 2023 $32 · 2024 $303 · 2025 $531
Food & beverage: $531
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $157 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $130 |
| Geron Corporation | 3 | $88 |
| Alkermes, Inc. | 3 | $59 |
| Neurocrine BioSciences, Inc. | 2 | $52 |
| ABBVIE INC. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
Products named: CAPLYTA, UZEDY, IMETELSTAT, ARISTADA, INGREZZA, AUSTEDO XR, VRAYLAR, COBENFY.
Industry payments across CA — which companies pay providers there.
